Abstract
Obesity is a positive predictor of surgical morbidity. There are few reports of laparoscopic cholecystectomy (LC) outcomes in obese patients. This study aimed to clarify this relationship. This retrospective study included patients who underwent LC at Showa University Northern Yokohama Hospital between January 2017 and April 2020. A total of 563 cases were examined and divided into two groups: obese (n = 142) (BMI ≥ 25 kg/m2) and non-obese (n = 241) (BMI < 25 kg/m2). The non-obese group had more female patients (54%), whereas the obese group had more male patients (59.1%). The obese group was younger (56.6 years). Preoperative laboratory data of liver function were within the normal range. The obese group had a significantly higher white blood cell (WBC) count (6420/μL), although this was within normal range. Operative time was significantly longer in the obese group (p = 0.0001). However, blood loss and conversion rate were not significantly different among the groups, neither were surgical outcomes, including postoperative hospital stay and complications. Male sex and previous abdominal surgery were risk factors for conversion, and only advanced age (≥ 79 years) was an independent predictor of postoperative complications as observed in the multivariate analysis. Although the operation time was prolonged in obese patients, operative factors and outcomes were not. Therefore, LC could be safely performed in obese patients with similar efficacy as in non-obese patients.
Similar content being viewed by others
Introduction
Obesity has become a global problem. An increasing obese population has become a national affliction not only in the United States1 and Europe but also in Asia and Japan2. Moreover, in the last 10 years, the prevalence of obesity has increased with age in Japan3, and the transition from overweight to obese has become greater in women than in men4.
Obesity has been reported as a positive predictor of surgical morbidity. Some previous reports have shown that obesity is a positive predictor of surgical morbidity or poor prognosis, for procedures such as gastrectomy5, colectomy6, hepatectomy7,8,9, and laparoscopic cholecystectomy (LC)10,11. Meanwhile, others have reported that obesity does not increase morbidity or mortality after gastrectomy12 and hepatectomy13.
LC is the standard operation for benign gallbladder lesions. Once complications occur, damage to the quality of live in patients is very deep. Only a few reports have assessed the impact of obesity-related comorbidities on the operative risk for patients after LC. This study aimed to compare outcomes between obese and non-obese patients after LC.
Materials and methods
A retrospective study was performed on patients who underwent LC at Showa University Northern Yokohama Hospital from January 2017 to April 2020. A total of 563 cases were examined. Data were divided into two groups: the obese group (n = 142) (body mass index [BMI] ≥ 25 kg/m2) and non-obese group (n = 241) (BMI < 25 kg/m2) (Fig. 1). BMI criteria were defined using the World Health Organization (WHO) classification cutoff value for Asian populations14.
Patient characteristics included age, sex, height, body weight, and BMI. Preoperative data included laboratory data, American Society of Anesthetists (ASA) physical status, previous abdominal surgery, and preoperative complications. Operative factors included total operative time and estimated blood loss. Postoperative outcomes, including conversion rate, postoperative complications, and hospital stays, were retrospectively compared between the two groups. For standardization purposes, complications were classified according to the Clavien-Dindo classification system15,16. Patients with Clavien-Dindo grade 2 or higher were deemed to have a complication. All LCs were performed for symptomatic gallstone disease with cholecystitis. We excluded emergency surgery, LCs for suspicious malignant diseases, or surgeries with percutaneous transhepatic gallbladder drainage. At our facility, emergency surgeries are usually performed at night, when the number of surgical staff is limited. Emergency surgery cases were excluded because scrub nurses are usually absent, which is likely to affect the operative time.
The indication for LC was benign gallbladder disease in all patients. Obesity has never been considered a contraindication for LC. All LCs were performed using the conventional 4-port technique in the supine position under general anesthesia. A trans-umbilical vertical incision was made with a 12-mm trocar using the open technique in the umbilicus to achieve carbon dioxide insufflation, and the intraabdominal pressure was maintained at 10 mmHg, and a 30° laparoscope was used through a 12-mm trocar. Then, one 5-mm trocar was inserted beneath the xiphoid, and two 5-mm trocars were inserted below the right costal arch. Intraoperative cholangiography was not performed routinely. Multiple surgeons performed the procedures.
Data analysis was performed using JMPPro 14 (SAS Institute Inc., Cary, NC, USA). For comparisons between the groups, a Chi-square test was used for categorical variables, and a Student's t test was used for quantitative variables. The results are expressed as the mean ± standard deviation. Multivariate logistic regression was used to identify other factors associated with increased conversion and postoperative complication rates. Probability p-values were considered statistically significant at < 0.05 level.
The Committee on Ethics of Showa University Medical School and IRB (Institutional Review Board) reviewed and approved the study protocols (approval code: No. 19H048), and all patients provided written informed consent. All procedures in this study were performed in accordance with the relevant guidelines and regulations.
Results
The results of patient characteristics are shown in Table 1. The non-obese group had a higher percentage of female patients (54%) whereas the obese group had a higher percentage of male patients (59%). However, there were 7 patients with a BMI > 35, and all of them were female (data not shown). The obese group was comprised of younger participants (56.6 y). There was no significant difference in height between the two groups. Mean BMI was 28.2 (kg/m2) in the obese group and 21.7 (kg/m2) in the non-obese group.
All preoperative laboratory data of liver function before surgery were within the normal range, and there was no significant difference between the two groups. However, there was a significant difference in the white blood cell (WBC) count in each group (Table 2). The higher WBC count (6420/μL) was in the obese group, although the WBC count remained in the normal range.
Preoperative factors are presented in Table 3. There were no significant differences in the American Society of Anesthetists classification scores; however, the scores were higher in the obese group. The rate of patients with a previous laparotomy was almost 25%, which was not significantly different between the two groups.
Regarding preoperative complications, diabetes and liver disease were more common in the obese group than in the non-obese group, and there was a significant difference (Table 4). Moreover, the incidence of gastrointestinal cancer was significantly lower in the obese group than in the non-obese group.
There were significant differences in the operative time, which was longer in the obese group than in the non-obese group (Table 5). However, considering blood loss (Table 5) and conversion rate (Table 6), there were no significant differences between the two groups.
Finally, significant differences in surgical outcomes, including postoperative hospital stay and complications, were not detected in the two groups (Table 6). The incidence of postoperative complications in the two groups was 1.2–1.4%, with no significant difference observed between them (Table 6).
Moreover, male sex and previous abdominal surgery were risk factors for conversion (Table 7), and only advanced age (≥ 79 years) was an independent predictor of postoperative complications as observed in the multivariate analysis (Table 8).
Discussion
Currently, obesity is a global problem. It has become a greater problem not only in Western countries but also in Japan. Our study showed that the higher the BMI, the higher the proportion of women and young people. This is similar to the findings of a previous report10 and seems to be a global trend.
According to WHO14, the Asian population has a different association between BMI, body fat percentage, and health risk than the European population. Therefore, it can be assumed that the health risk cut-off point for Asians is lower than the existing WHO cut-off point. Some reports used 25 kg/m2 as a BMI cut-off point for obesity in the Japanese5 and Korean17 populations, respectively. Considering that we are an Asian (Japanese) population, we also used 25 kg/m2 as a BMI cut-off point for obesity in our study.
The preoperative WBC count was significantly higher with a higher BMI. The exact mechanisms for preoperative elevation of WBC are unexplained, but it has been reported that the incidence of histological liver damage is very high in obese patients18,19. This may be a reason why the WBC count tends to increase.
The higher the BMI of the patient, the worse the ASA score (Table 3). It is thought that this is because diabetes and liver disease are common in obesity18,19,20. These preoperative complications were more frequent in obesity, and there was also a significant difference in our results (Table 4). However, it is unlikely that preoperative complications influenced the operative time and postoperative results. Moreover, gastrointestinal cancer was significantly more common in the non-obese group, probably because patients with a history of cancer are less likely to become obese. Especially in postoperative patients with gastric cancer, it is said that there are many cases of weight loss, as it was reported that 67% of patients lost more than 10% of their body weight after surgery21. In other words, it seems that the interpretation that the history of cancer is almost unrelated to obesity is correct rather than the interpretation that it is more common in the non-obese group.
According to various reports, patients who had a longer operation time in LC were more likely to have biliary injury22, and obese patients had a higher conversion rate10 as well as a higher proportion of biliary injury11. However, our data showed no significant difference in intra- and postoperative complications, and even in obese patients, postoperative complications were as low as 1.4%. In addition, there were no cases of intraoperative biliary tract injury, and all LCs could be performed safely. As for the surgical factors, the higher the BMI of the patient, the longer the operative time, but the amount of bleeding was not significantly different.
Although it is recommended to confirm the “critical view of safety” (CVS) to safely perform LC23, the operative time was significantly longer in obese patients because the amount of fat in the abdominal cavity was large which took a long time to remove and, probably, also to confirm CVS. In addition, when it is difficult to confirm the critical view of safety, the fundus-first technique (dome down, antegrade dissection) may have been adopted more often without being particular about confirmation of CVS, which may have lengthened the operative time24,25. We have adopted this method because there are reports that it is safer to complete cholecystectomy by switching to a method such as the fundus-first technique24,25. Additionally, it was difficult to dissect the gallbladder from the gallbladder bed. Furthermore, since obese patients have thick subcutaneous fat and a depressed umbilicus, it is very difficult to close the abdominal wall, which could be considered as one of the factors that make the operative time prolonged compared to non-obese patients.
However, there were no significant differences in the length of hospital stay, conversion rate, or postoperative complication rate, except operative time. Moreover, there were no intraoperative complications such as iatrogenic biliary tract injury, which is considered as one of the more serious complications. Furthermore, there were no unfortunate cases of postoperative death (Table 9).
Chang et al.26 reported that only acute cholecystitis was a predictor for conversion and complications in Taiwanese patients. Neylan et al.27 analyzed cases of acute cholecystitis and reported that an intended open procedure and conversion were associated with an increased risk of death and serious morbidity. In addition, Franks et al.28 reported that male sex and emergent cholecystectomy were independent predictors of increased conversions and complications, and diabetes was a risk factor for conversion, whereas age > 65 years was a risk factor for complications. On the other hand, in our study, scheduled surgeries for cholecystitis were all laparoscopic cholecystectomies which did not include the intended laparotomy, hence it can be considered as a study that eliminates such biases. In addition, the bias of emergency surgeries was eliminated in our study. Furthermore, our study targeted a population of Asians, especially the Japanese. Of note, we found that male sex and a history of abdominal surgery were risk factors for conversion, and only advanced age (≥ 79 years) was an independent predictor of postoperative complications as observed in the multivariate analysis.
The degree of obesity in a patient affected and prolonged the operation time but did not affect the patient's outcome in this study.
The limitations of our study are that the analysis was limited to a single institution and that the study had a retrospective design. Further analysis and more patients are needed to confirm the effect of our study.
In conclusion, although the operation time was prolonged in obese patients, the bleeding volume, conversion rate, complications, and length of stay in the hospital were not prolonged; therefore, LC could also be safely performed in obese patients with similar efficacy as in non-obese patients.
References
Singh, G. K., Siahpush, M., Hiatt, R. A. & Timsina, L. R. Dramatic increases in obesity and overweight prevalence and body mass index among ethnic-immigrant and social class groups in the United States, 1976–2008. J. Community Health 36, 94–110 (2011).
McCurry, J. Japan battles with obesity. Lancet 369, 451–452 (2007).
Kuwahara, K. et al. Current status of health among workers in Japan: Results from the Japan Epidemiology Collaboration on Occupational Health Study. Ind. Health 54, 505–514 (2016).
Hasegawa, M. et al. Five-year cumulative incidence of overweight and obesity, and longitudinal change in body mass index in Japanese workers: The Japan Epidemiology Collaboration on Occupational Health Study. J. Occup. Health 62, e12095 (2020).
Shimada, S. et al. Impact of obesity on short- and long-term outcomes of laparoscopy assisted distal gastrectomy for gastric cancer. Surg. Endosc. 32, 358–366 (2018).
Champagne, B. J. et al. Laparoscopic colectomy in the obese, morbidly obese, and super morbidly obese: When does weight matter?. Int. J. Colorectal Dis. 32, 1447–1451 (2017).
Yoshida, N. et al. Surgical outcomes in patients with hepatocellular carcinoma associated with metabolic syndrome. World J. Surg. 39, 471–477 (2015).
Langella, S. et al. Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases. Surgery 158, 1521–1529 (2015).
Viganò, L. et al. Liver resection in obese patients: Results of a case–control study. HPB 13, 103–111 (2011).
Paajanen, H. et al. Impact of obesity and associated diseases on outcome after laparoscopic cholecystectomy. Surg. Laparosc. Endosc. Percutan. Tech. 22, 509–513 (2012).
Aziz, H., Pandit, V., Joseph, B., Jie, T. & Ong, E. Age and obesity are independent predictors of bile duct injuries in patients undergoing laparoscopic cholecystectomy. World J. Surg. 39, 1804–1808 (2015).
Chen, H. & Sui, W. Influence of obesity on short- and long-term outcomes after laparoscopic distal gastrectomy for gastric cancer. J. BUON 22, 417–423 (2017).
Guo, Z., Zhang, J., Jiang, J. H., Li, L. Q. & Xiang, B. D. Obesity does not influence outcomes in hepatocellular carcinoma patients following curative hepatectomy. PLoS ONE 10, e0125649 (2015).
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004).
Dindo, D., Demartines, N. & Clavien, P. A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240, 205–213 (2004).
Clavien, P. A., Sanabria, J. R. & Strasberg, S. M. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111, 518–526 (1992).
Jang, E. J. et al. Comparison of outcomes after single-port laparoscopic cholecystectomy in relation to patient Body Mass Index. JSLS 18(3), e2014.00048 (2014).
Gaudio, A. D., Boschi, L., Gaudio, G. A. D., Mastrangelo, L. & Munari, D. Liver damage in obese patients. Obes. Surg. 12, 802–804 (2002).
Kroh, M., Liu, R. & Chand, B. Laparoscopic bariatric surgery: What else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. Surg. Endosc. 21, 1957–1960 (2007).
Boffetta, P. et al. Body mass index and diabetes in Asia: A cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS ONE 6, e19930 (2011).
Climent, M. et al. Weight loss and quality of life in patients surviving 2 years after gastric cancer resection. Eur. J. Surg. Oncol. 43, 1337–1343 (2017).
Subhas, G. et al. Prolonged (longer than 3 hours) laparoscopic cholecystectomy: Reasons and results. Am. Surg. 77, 981–984 (2011).
Strasberg, S. M., Eagon, C. J. & Drebin, J. A. The “Hidden Cystic Duct” syndrome and the infundibular technique of laparoscopic cholecystectomy—The danger of the false infundibulum. J. Am. Coll. Surg. 191, 661–667 (2000).
Sormaz, İC., Soytaş, Y., Gök, A. F. K., Özgür, İ & Avtan, L. Fundus-first technique and partial cholecystectomy for difficult laparoscopic cholecystectomies. Ulus Travma Acil Cerrahi Derg 24, 66–70 (2018).
Tartaglia, N. et al. Laparoscopic antegrade cholecystectomy: A standard procedure?. Open Med. 11, 429–432 (2016).
Chang, W. T. et al. The impact of body mass index on laparoscopic cholecystectomy in Taiwan: An oriental experience. J. Hepatobiliary Pancreat. Surg. 16(5), 648–654 (2009).
Neylan, C. J. et al. The role of body mass index class in cholecystectomy after acute cholecystitis: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery 160, 699–707 (2016).
Farkas, D. T., Moradi, D., Moaddel, D., Nagpal, K. & Cosgrove, J. M. The impact of body mass index on outcomes after laparoscopic cholecystectomy. Surg. Endosc. 26, 964–969 (2012).
Author information
Authors and Affiliations
Contributions
Y.E. wrote the main manuscript text and prepared the figure and tables. Y.E., K.T., T.Ha., T.Hi., H.S., K.S., Y.T., J.S., S.O., S.S., K.N., Y.T., and S.M. performed surgery and analyzed the data. T.A., N.S., F.I., M.M., and S.K. planned and supervised the work. All authors have revised the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Enami, Y., Aoki, T., Tomioka, K. et al. Obesity is not a risk factor for either mortality or complications after laparoscopic cholecystectomy for cholecystitis. Sci Rep 11, 2384 (2021). https://doi.org/10.1038/s41598-021-81963-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-81963-5
This article is cited by
-
Development of a prospective biliary dashboard to compare performance and surgical cost
Surgical Endoscopy (2023)
-
Operative Difficulty, Morbidity and Mortality Are Unrelated to Obesity in Elective or Emergency Laparoscopic Cholecystectomy and Bile Duct Exploration
Journal of Gastrointestinal Surgery (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.